All In Biotech

Drug Trial Radar · NCT06073821

Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)

A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 652 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

652

Planned (sponsor's estimate)

Start

Nov 11, 2023

Primary completion

Feb 2032

Study completion Dec 2032

Sponsor

Lead sponsor
BeOne MedicinesBeOne Medicines (BeiGene) (ONC)
Sponsor type
Industry
First posted
Oct 10, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective of this study is to compare the efficacy of sonrotoclax plus zanubrutinib versus venetoclax plus obinutuzumab in participants with chronic lymphocytic leukemia (CLL)

Conditions

  • CLL

Interventions

  • SonrotoclaxDrug

    Administered orally

  • ZanubrutinibDrug

    Administered orally

  • VenetoclaxDrug

    Administered orally

  • ObinutuzumabDrug

    Administered intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cohort 1: Progression Free Survival (PFS)Time frame: Up to approximately 9 years
  2. Cohort 1: Rate of Undetectable Measurable Residual DiseaseTime frame: Up to one and a half years

Locations

201 sites in 21 countries. Site status is shown where the registry gives one.

  • Alaska Oncology and Hematology, Llc

    Anchorage, Alaska

  • City of Hope National Medical Center

    Duarte, California

  • University of California San Diego (Ucsd) Moores Cancer Center

    La Jolla, California

  • Valkyrie Clinical Trials

    Los Angeles, California

  • UCLA Department of Medicine Hematologyoncology

    Los Angeles, California

  • Chao Family Comprehensive Cancer Center

    Orange, California

  • Stanford Medicine

    Palo Alto, California

  • University of Colorado Cancer Center

    Aurora, Colorado

  • Medstar Georgetown University Hospital

    Washington D.C., District of Columbia

  • Mount Sinai Medical Center Braman Comprehensive Cancer Center

    Miami, Florida

  • Moffitt Cancer Center

    Tampa, Florida

  • Southeastern Regional Medical Center

    Newnan, Georgia

  • Northwestern University

    Chicago, Illinois

  • Illinois Cancercare, Pc

    Peoria, Illinois

  • Fort Wayne Medical Oncology and Hematology

    Fort Wayne, Indiana

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Mission Cancer and Blood

    Waukee, Iowa

  • The University of Kansas Cancer Center

    Westwood, Kansas

  • Norton Cancer Institute Pavilion

    Louisville, Kentucky

  • Ochsner Clinic Foundation

    New Orleans, Louisiana

  • University of Minnesota

    Minneapolis, Minnesota

  • Washington University School of Medicine

    St Louis, Missouri

  • John Theurer Cancer Center Hackensack University Medical Center

    Hackensack, New Jersey

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey

  • Columbia University Medical Center

    New York, New York

  • Optum Medical Care, Pc

    Westbury, New York

  • University of North Carolina At Chapel Hill

    Chapel Hill, North Carolina

  • Atrium Health Levine Cancer Institute (Lci)

    Charlotte, North Carolina

  • Duke University Medical Center

    Durham, North Carolina

  • Cleveland Clinic Foundation

    Cleveland, Ohio

  • The James Cancer Hospital and Solove Research Institute At Ohio State University

    Columbus, Ohio

  • Oncology Associates of Oregon Willamette Valley Cancer Center

    Eugene, Oregon

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania

  • Scri Tennessee Oncology Chattanooga

    Chattanooga, Tennessee

  • Huntsman Cancer Institute

    Salt Lake City, Utah

  • Virginia Cancer Institute

    Richmond, Virginia

  • Vcu Health System Massey Comprehensive Cancer Center

    Richmond, Virginia

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington

  • Gunderson Health System

    La Crosse, Wisconsin

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

Showing 40 of 201 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.